drug-therapy

Documents about drug-therapy

• Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate#908438ClinicalTrials.gov
• The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression#915361ClinicalTrials.gov
• 3D-Printed Multichannel Scaffold with Brain Derived Neurotrophic Factor Drug Delivery as a Functional Therapy to Peripheral Nerve Injuries#983572eScholarship
• An [^11C]T-773 Positron Emission Tomography (PET) Study to Determine Phosphodiesterase10A Occupancy by TAK-063#992632ClinicalTrials.gov
• OPTIMIZE-APT: Tailored Versus Conventional Antiplatelet Therapy After Intravascular Imaging-guided Drug-eluting Stent Implantation#1008799ClinicalTrials.gov
• Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout#1029838ClinicalTrials.gov
• A Study of Surgical Interventions in Fistulizing Conditions#1030998ClinicalTrials.gov
• Amitriptyline to Prevent Headache After Traumatic Brain Injury#1044745ClinicalTrials.gov
• UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients#1045717ClinicalTrials.gov
• Transition to dolutegravir-based ART in 35 low- and middle-income countries : a global survey of HIV care clinics.#361127SUNScholar
• Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3#813434ClinicalTrials.gov
• Genetic variants associated with cancer therapy-induced cardiomyopathy#648481Spiral
• Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients#890789ClinicalTrials.gov
• Comparison Three vs Six Months of Dual Anti-platelet Therapy After Sirolimus-eluting Stent Implantation#830365ClinicalTrials.gov
• A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs#895449ClinicalTrials.gov
• Towards Mechanism‐Informed Treatments for Mental Health#213143HAL (France)
• Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer#287524ClinicalTrials.gov
• Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma#356119Zenodo (CERN)
• Fucoidan-Functionalized Nanoparticles for Antimycobacterial Therapy: A Promising Approach against Drug-Resistant Mycobacterium tuberculosis Strains.#399761NCBI PubMed Central
• Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.#662704NCBI PubMed Central
• Sensory neuron BRAF mediates opioid-induced hyperalgesia and tolerance via presynaptic NMDA receptor hyperactivity#676451Europe PMC
• Negative Pressure Wound Therapy as a Drug Delivery System (ADANPWT)#830721ClinicalTrials.gov
• Targeting Effective Analgesia in Clinics for HIV - Patient Cohort#841571ClinicalTrials.gov
• The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta#854715ClinicalTrials.gov
• Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA)#867950ClinicalTrials.gov
• STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent Implantation#877579ClinicalTrials.gov
• Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors#880119ClinicalTrials.gov
• Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE（PATH-STROKE）#880655ClinicalTrials.gov
• A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma#903627ClinicalTrials.gov
• Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic Cardiomyopathy#903733ClinicalTrials.gov
• Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer#908946ClinicalTrials.gov
• A Study to Evaluate the Effect of Food on the Pharmacokinetics of TAK-831 Tablet Formulation#910422ClinicalTrials.gov
• A Study of Dexlansoprazole Modified Release (MR) in Gastroesophageal Reflux Disease (GERD) Participants in the Russian Federation#911644ClinicalTrials.gov
• Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia#992836ClinicalTrials.gov
• HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1#1032067ClinicalTrials.gov
• A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.#830998ClinicalTrials.gov
• Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.#803654ClinicalTrials.gov
• Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy#838189ClinicalTrials.gov
• Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer#848080ClinicalTrials.gov
• The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs#891762ClinicalTrials.gov
• Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir#917847ClinicalTrials.gov
• Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients#1007518ClinicalTrials.gov
• Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report#923133IRIS
• Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)#1030691ClinicalTrials.gov
• HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)#909400ClinicalTrials.gov
• Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer#911459ClinicalTrials.gov
• Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)#912782ClinicalTrials.gov
• Guideline for the pharmacological treatment of hypertension in adults#149473WHO IRIS
• Web basEd soCial Media tecHnology to Improvement in Adherence to Dual anTiplatelet Therapy Following Drug-Eluting Stent Implantation#162336ClinicalTrials.gov
• Composing drug delivery with light distribution improvement: the use of dissolving microneedles in skin cancer with photodynamic therapy.#170718NCBI PubMed Central